Dianthus Therapeutics Q1 2026 Earnings EPS Beat Amid PreRevenue Stage UDR Q1 2026 Earnings Stellar EPS Surprise of 413 Above Estimates MX Q1 2026 Earnings Strong EPS Beat Provides Some Relief as Revenue Picture Remains Opaque MITP Q1 2026 Earnings EPS Surpasses Estimates by 535 Fox Corporation FOXA Q1 2026 Earnings Strong EPS Beat Drives Positive Surprise but Stock Edges Lower TPVG Q1 2026 Earnings Net Investment Income Misses Estimates as Stock Edges Higher